| Symbol | CELZ |
|---|---|
| Name | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. |
| Sector | FINANCE |
| Region | North America |
| Industry | Finance: Consumer Services |
| Address | 211 E OSBORN ROAD, PHOENIX, Arizona, 85012, United States |
| Telephone | +1 480 399-2822 |
| Fax | — |
| — | |
| Website | https://www.creativemedicaltechnology.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001187953 |
| Description | Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid-derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues. Additional info from NASDAQ: |
New Form S-3 - CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. <b>Filed:</b> 2026-07-24 <b>AccNo:</b> 0001477932-26-004498 <b>Size:</b> 475 KB
Read moreNew Form PRE 14A - CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. <b>Filed:</b> 2026-07-01 <b>AccNo:</b> 0001477932-26-004146 <b>Size:</b> 757 KB
Read moreCreative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $4.5 Million Gross Proceeds
Read moreNew Form RW - CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. <b>Filed:</b> 2026-06-30 <b>AccNo:</b> 0001477932-26-004097 <b>Size:</b> 16 KB
Read moreNew Form S-1 - CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. <b>Filed:</b> 2026-06-25 <b>AccNo:</b> 0001477932-26-004010 <b>Size:</b> 1 MB
Read moreCreative Medical Technology Holdings Expands ADAPT Trial Under New FDA Clearance and Rapidly Advances Toward Phase 3 Planning for Olastrocel in Chronic Lower Back Pain
Read moreCreative Medical Technology Holdings, Inc. Advances Project PHOENIX into Nationwide AI Driven Virtual Data Collection Phase for U.S. Veterans Exposed to Burn Pits and Toxic Hazards
Read moreCreative Medical Technology Holdings, Inc. Reports Breakthrough 93% Response Rate in Ultrasome™ Knee Osteoarthritis Program, Expanding CELZ-201 Platform into Scalable Cell-Free Regenerative Therapies
Read moreNew Form 10-K/A - CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. <b>Filed:</b> 2026-04-24 <b>AccNo:</b> 0001477932-26-002534 <b>Size:</b> 374 KB
Read more